Skip to main content
. 2023 Jun 17;16(3):431–450. doi: 10.1016/j.jcmgh.2023.06.001

Table 2.

Demographics of IBD-BIOM Validation Set

CD (n = 123) SC (n = 84) P value SC vs CD Healthy volunteers (n = 114) P value HL vs CD
Age, median (IQR) 32.4 (24.9–50.7) 32.8 (26.4–45.5) .9a 32.3
26.4–40.6)
.4a
Females, n (%) 58 (47.9) 39 (52.7) .6b 59 (50.4) .8b
Smoking status
 Current 53 17 Current vs ex/never 24 Current vs ex/never
 Ex 29 17 .005 32 .0005
 Never 39 40 Ever vs never 56 Ever vs never
 Unknown 0 0 .004 5 .008
CRP 8 (2–23) 0 (0–3.5) .006a
ESR 18 (5–39) 6 (4.5–7.5) .002a
FC 495 (135–828) 19 (19–37) .0001a

CD, Crohn’s disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; FC, fecal calprotectin; HL, healthy laboratory volunteers; IQR, interquartile range; SC, symptomatic control subjects; UC, ulcerative colitis.

Adapted with permission from Ventham et al.

a

Wilcoxon rank sum test.

b

Chi-square test.